HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer

BACKGROUND: The clinical significance of intratumoral human epidermal growth factor receptor 2 (HER2) heterogeneity is unclear for HER2-positive gastric cancer, although it has been reported to be a significant prognosticator for HER2-positive breast cancer, which has received trastuzumab-based chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaito, Akio, Kuwata, Takeshi, Tokunaga, Masanori, Shitara, Kohei, Sato, Reo, Akimoto, Tetsuo, Kinoshita, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695545/
https://www.ncbi.nlm.nih.gov/pubmed/31423428
http://dx.doi.org/10.12998/wjcc.v7.i15.1964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695545/
https://www.ncbi.nlm.nih.gov/pubmed/31423428
http://dx.doi.org/10.12998/wjcc.v7.i15.1964

Ejemplares similares